Home › Funds › Everstar Asset Management, LLC › AQST

Everstar Asset Management, LLC position in AQST

AQUESTIVE THERAPEUTICS INC COM · Health Care

Everstar Asset Management, LLC reported holding 611,943 shares of AQST (AQUESTIVE THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 1.23% of its reported portfolio and ranking #11 among its reported holdings. Everstar Asset Management, LLC has disclosed AQST holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)611.94K sh
Reported value held$2.55M
Portfolio Weight1.23%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Everstar Asset Management, LLC's AQST position evolved

Everstar Asset Management, LLC first disclosed a stake in AQST in Q3 2024 at 400,125 shares (US$2.0M). The position peaked in Q2 2026 at 611,943 shares, worth US$2.5M. Across 8 filings, Everstar Asset Management, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 611,943 shares valued at US$2.5M — an increase of 58,762 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares fell 19% over the following quarter), a 120% increase in Q2 2025 (shares rose 69% over the following quarter), a 60% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 400.12K $1.99M New
Q4 2024 216.22K $769.75K Reduce
Q1 2025 300.00K $870.00K Add
Q2 2025 658.61K $2.18M Add
Q3 2025 368.29K $2.06M Reduce
Q4 2025 344.80K $2.23M Reduce
Q1 2026 553.18K $2.30M Add
Q2 2026 611.94K $2.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AQST and 13F data

AQST (AQUESTIVE THERAPEUTICS INC COM) is a Health Care company. 40 other funds we track also report a position in AQST — the largest reported positions include Bratton Capital Management, L.P. (US$40.8M), Samsara BioCapital, LLC (US$10.4M), Sio Capital Management, LLC (US$6.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AQST

All AQST fund holders →

FAQ

How long has Everstar Asset Management, LLC held AQST?

Everstar Asset Management, LLC has disclosed AQST holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Everstar Asset Management, LLC's current position in AQST?

As of Q2 2026, Everstar Asset Management, LLC holds 611.94K shares of AQST (AQUESTIVE THERAPEUTICS INC COM), valued at $2.55M, representing 1.23% of its reported portfolio and ranking #11.

Has Everstar Asset Management, LLC been buying or selling AQST?

In the latest 13F filing (Q2 2026), Everstar Asset Management, LLC increased its position in AQST. The position peaked in Q2 2026 at 611.94K shares.

Which other funds hold AQST?

Other major institutional holders of AQST include Bratton Capital Management, L.P., Samsara BioCapital, LLC, Sio Capital Management, LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.